Mendlein John

Mendlein John is listed in filings as Director at FATE THERAPEUTICS INC. This profile follows SEC Form 4 activity through May 30, 2025, including 2 public disclosures. Recent filings connect the profile to FATE THERAPEUTICS INC (FATE) and Omega Therapeutics, Inc. (OMGA). The current snapshot covers public activity from Jun 21, 2024 to May 30, 2025. Reported amounts are shown as $72.6K to $55.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.